QuidelOrtho says 90% of Q4 sales were recurring

Sees continued momentum heading into 2025. Says continuing to drive cost reduction initiatives. Sees margin growth over next few years producing “benchmark profitability.” Says capital allocation priority is paying down debt. Sees FY25 tax rate 24%. Comments taken from Q4 earnings conference call.